Human papillomavirus infection in relation to mild dyskaryosis in conventional cervical cytology

European Journal of Gynaecological Oncology

Volumn 26, Issue 1, 2005, Pages 39-42

  Bokal, E Vrtačnik ^a   Rakar, S ^a   Mozina A ^a   Poljak, M ^b  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Cervical cancer; Human papillomavirus; Mild dyskaryosis

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CONDYLOMA; CONTROLLED STUDY; DYSKARYOSIS; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN TISSUE; LABORATORY TEST; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; SEROPREVALENCE; SLOVENIA; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS STRAIN; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; SLOVENIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 14644411713     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Nobbenhuis M.A.E., Walboomers J.M., Helmerhorst T.J., Rozendaal L., Remmink A.J., Risse E.K. et al.: "Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening: a prospective study". Lancet, 1999, 354, 20.
2. Nanda K., McCrory D.C., Myers E.R., Bastian L.A., Hasselblad V., Hickey J.D. et al.: "Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review". Ann. Intern. Med., 2000, 132, 810.
3. Cuzick J., Beverley E., Ho L., Terry G., Sapper H., Mielzynska I. et al.: "HPV testing in primary screening of older women". Br. J. Cancer, 1999, 81, 554.
4. Schiffman M., Herrero R., Hildesheim A., Sherman M.E., Bratti M., Wacholder S. et al.: "HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica". JAMA, 2000, 283, 87.
5. Vizcaino A.P., Moreno V., Bosch F.X., Munoz N., Barros-Dios X.M., Borras J. et al.: "International trends in incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas". Int. J. Cancer., 1998, 75, 536.
6. Vizcaino A.P., Moreno V., Bosch F.X., Munoz N., Barros-Dios X.M., Borras J. et al.: "International trends in incidence of cervical cancer: II. Squamous-cell carcinoma". Int. J. Cancer., 2000, 86, 429.
7. Manos M.M., Kinney W.K., Hurley L.B., Sherman M.E., Shieh-Ngai J., Kurman R.J. et al.: "Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results". JAMA, 1999, 281, 1605.
8. Bergeron C., Jeannel D., Poveda J., Cassonnet P., Orth G.: "Human papillomavirus testing in women with mild cytologic atypia". Obstet. Gynecol., 2000, 95, 821.
9. Cuzick J., Szarewski A., Cubie H., Hulman G., Kitchener H., Luesley D. et al.: "Management of women who test positive for high-risk types of human papillomavirus: the HART study". Lancet, 2003, 362, 1871.
10. Poljak M., Seme K.: "Rapid detection and typing of human papillomaviruses by consensus polymerase chain reaction and enzyme-linked immunosorbent assay". J. Virol. Methods., 1996, 56, 231.
11. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Casstellsague X., Shah K.V. et al.: International agency for research on cancer multicenter cervical cancer study group. Epidemiologic classification of human papillomavirus types associated with cervical cancer". N. Engl. J. Med., 2003, 348, 518.
12. Franco E., Monsonego J.: "New developments in cervical cancer screening and prevention". Oxford, Blackwell Science Ltd, 1997.
13. Wright T.C. Jr., Lorincz A., Ferris D.G., Richart R.M., Ferenczy A., Mielzynska I. et al.: "Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears". Am. J. Obstet. Gynecol., 1998, 178, 962.
14. Sherman M.E., Schiffman M., Cox J.T.: "Atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study group: Effects of age and human papilloma viral load on colposcopy triage data from the randomized atypical squamous cells of undetermined significance/low- grade squamous intraepithelial lesion triage study (ALTS)". J. Natl. Cancer. Inst. 2002, 94, 102.
15. Monsonego J.: "Global challenges of cervical cancer prevention". Eur. J. Gynaecol. Oncol., 2000, 21, 533.
16. Arnold K.: "Guidelines for abnormal Pap tests: Do physicians follow them?". J. Natl. Cancer. Inst., 2002, 94, 880.
17. Mandelblatt J.S., Lawrence W.F., Womack S.M., Jacobson D., Yi B., Hwang Y.T. et al.: "Benefits and costs of using HPV testing to screen for cervical cancer". JAMA, 2002, 287, 2372.
18. Kim J.J., Wright T.C., Goldie S.J.: "Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance". JAMA, 2002, 287, 2382.
19. "Cancer Incidence in Slovenia 2000". Report No 42, Ljubljana: 2003.
20. Tachezy R., Hamsikova E., Hajek T., Mikyskova I., Smahel M., Van Ranst M. et al.: "Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV 16, 18 and 33 virus-like particles". J. Med. Virol., 1999, 58, 378.
21. Chan P.K., Li W.H., Chan M.Y., Ma W.L., Cheung J.L., Cheng A.C.: "High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions". J. Med. Virol., 1999, 59, 232.
22. Liaw K.L., Glass A.G., Manos M.M., Greer C.E., Scott D.R., Sherman M. et al.: "Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions". J. Natl. Cancer. Inst., 1999, 91, 954.
23. th International Multidisciplinary Congress: Preventing and Controlling Cervical Cancer in the New Millennium" (abstract PS7-2a). April 13-16, 2003.